On Friday, Shares of Apple Inc. (NASDAQ:AAPL), lost -0.59% to $126.75.
Apple’s streaming service officially launches on Tuesday, putting the tech giant into what has evolved into the fastest-growing way that consumers listen to music, according to Los Angeles Times.
The Cupertino, Calif.-based company hopes many of the 800 million users with iTunes accounts will sign up for the new Apple Music service, which will launch with a 90-day free trial. Music and tech industry observers expect Apple devotees will sign up for the offer in droves to take the streaming service for a test spin — but, there’s still a long way to go before it knocks out industry leader Spotify. Los Angeles Times Reports.
Apple Inc. designs, manufactures, and markets mobile communication and media devices, personal computers, watches, and portable digital music players worldwide. The company also sells related software, services, accessories, networking solutions, and third-party digital content and applications.
Shares of Ally Financial Inc. (NYSE:ALLY), declined -0.64% to $23.34, during its last trading session.
Ally Financial, has planned the release of its second quarter 2015 financial results for Tuesday, July 28, 2015. The press release will be issued at 7:30 a.m. EDT via PR Newswire and on the Ally Media Center website (http://media.ally.com).
Ally will host a conference call at 9:00 a.m. EDT to review the company’s performance.
Ally Financial Inc. provides financial products and services primarily to automotive dealers and their customers in the United States. It offers dealer financial services, counting a range of financial services and insurance products to automotive dealers and retail customers.
Finally, Bio-Path Holdings, Inc. (NASDAQ:BPTH), ended its last trade with -6.57% loss, and closed at $1.28.
Bio-Path Holdings, declared it has established an “at-the-market” (“ATM”) program through which it may offer and sell up to $25 million of common stock from time to time, at Bio-Path’s discretion, through Cantor Fitzgerald & Co., acting as sales agent. Sales of Bio-Path common stock under the ATM program may be made directly on or through the Nasdaq Capital Market, among other methods.
The offer and sale of shares of common stock under the ATM program will be made following a prospectus supplement to Bio-Path’s prospectus dated January 13, 2014, filed as part of the Company’s shelf registration statement on Form S-3 (file no. 333-192102), which was filed with, and declared effective by, the U.S. Securities Exchange Commission. The ATM offering may be made only by means of a prospectus supplement and the related prospectus.
Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
